"Founded in 2004 by industry veteran, Dr. Joseph Kwentus, Precise Research Centers is proud to serve as the premier clinical research site and mental health clinic of its kind in Mississippi."

During the past decade, Precise Research Centers conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 36 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 17 clinical trials were completed. i.e. 106.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Precise Research Centers" #1 sponsor was "Sunovion" with 9 trials, followed by "Hoffmann-La Roche" with 8 trials sponsored, "Pfizer" with 7 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 6 trials sponsored and "Boehringer Ingelheim" with 6 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Precise Research Centers" #1 collaborator was "Otsuka America Pharmaceutical" with 2 trials as a collaborator, "Gedeon Richter Ltd." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Precise Research Centers" are "Schizophrenia" (12 trials), "Alzheimer's Disease" (7 trials), "Depressive Disorder, Major" (7 trials), "Alzheimer Disease" (4 trials) and "Major Depressive Disorder" (3 trials). Many other conditions were trialed in "Precise Research Centers" in a lesser frequency.

Most popular intervention types in "Precise Research Centers" are "Drug" (62 trials), "Other" (5 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Rapastinel" (6 trials), "placebo" (4 trials), "Crenezumab" (3 trials) and "RBP-6000" (3 trials). Other intervention names were less common.

The vast majority of trials in "Precise Research Centers" are 67 trials for "All" genders.

Currently, there are NaN active trials in "Precise Research Centers". undefined are not yet recruiting, 11 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 39 completed trials in Precise Research Centers, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Precise Research Centers, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 2 trials that are defined as “Not Applicable".